Takeda Pharmaceutical Company Limited announced new assignments of Directors. New assignment of Non-Audit and Supervisory Committee Directors effective June 29, 2021: Christophe Weber as internal existing representative director, president & chief executive officer; Masato Iwasaki as internal existing representative director, japan general affairs; Andrew Plump as internal existing director, president, research & development; Constantine Saroukos as internal existing director, chief financial officer; Masahiro Sakane as external existing external director, chair of the board meeting; Olivier Bohuon as external existing external director; Jean-Luc Butel as external existing external director; Ian Clark as external existing external director; Yoshiaki Fujimori as external existing external director; Steven Gillis as external existing external director; Shiro Kuniya as external existing external director; Toshiyuki Shiga as external existing external director. New assignment of audit and supervisory committee directors effective June 29, 2021: Koji Hatsukawa as external director, chairperson of audit and supervisory committee; Emiko Higashi as external director, audit and supervisory committee member; Masami Iijima as new external director, audit and supervisory committee member; Michel Orsinger as external director, audit and supervisory committee member.